RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. TPG Biotech
T

TPG Biotech portfolio

TPG Biotech has 1 portfolio company on record at Recent Funding. Its most recent investment on record is Avalyn Pharma's $100M Series B+ round in September 2023, alongside Wellington Management, Vida Ventures, T. Rowe Price and 6 others. That company is in Health and bio. It has co-invested with RiverVest, Pivotal bioVenture Partners and Wellington Management, most often RiverVest (2 rounds).

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $135.5M.
Latest deal: Avalyn Pharma · Sep 27, 2023.

What TPG Biotech invests in

How TPG Biotech invests

StageDealsCapital in rounds
Series B+ 2 100%$135.5M
YearDealsCapital in rounds
2020 1 50%$35.5M
2023 1 50%$100M

Share is of the 2 rounds on Recent Funding that name TPG Biotech. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

TPG Biotech portfolio companies

CompanyRound with TPG BiotechTotal raisedLatest raise
AAvalyn Pharma
Health and bio
Series B+ · $100M$135.5MSep 27, 2023
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists TPG Biotech, which is a subset of its real portfolio. API: /api/v1/investors/tpg-biotech (get a free API key). More: the most active VC firms and new venture capital funds.